ArticleJournal of fluorescence2025
Bio-Conjugated Carbon Quantum Dots for Intracellular Uptake and Bioimaging Applications.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Quantum dot enhanced photonic biosensors for single cell analysis from synthesis to clinical application.Discover nano · 2026Review
- Carbon Quantum Dots as Versatile Nanosystems for Biomedical Innovation: Mechanisms, Applications, and Translational Prospects.British journal of biomedical science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Carbon quantum dots (CQDs) demonstrate outstanding biocompatibility and optical properties, making them ideal for monitoring cellular uptake. Due to their ultra-small size (typically < 10 nm) and fluorescent nature, CQDs hold significant potential as nanoparticles for bioimaging and tracking intracellular processes. The study examined the optimization parameters for conjugating calf thymus DNA (Ct-DNA) to CQDs to facilitate Ct-DNA internalization in mouse fibroblast cells (L929) and human breast cancer cells (MCF-7). The formation of the CQD-Ct-DNA complex was confirmed by various characterization techniques such as, UV-Vis spectroscopy, fluorescence spectroscopy, transmission electron microscopy, and zeta potential analysis. The CQD-Ct-DNA complex, at a 600 µg/mL concentration, demonstrated up to 83.7% cell viability for the L929 cell line and 75.6% for the MCF7 cell lines. The research also compared the transfection ability of CQD with commonly used transfection agents lipofectamine and Polyethyleneimine (PEI) for Ct-DNA internalization. The results demonstrated that CQD could efficiently internalize Ct-DNA compared to the other agents. Thus, the CQD-Ct-DNA complex shows promising potential in bioimaging applications as an effective non-viral vector.
Indexed as
Identifiers
39786694What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.